Biotech · Private company · Kenilworth, IL, US
Synapticure, Inc.
Track this companyFree. Adds Synapticure, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- 3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic developmentFiscal year 2026 · $1.2MNIH RePORTER 5R44NS143521-02 · fetched Nov 12, 2026
- 3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic developmentFiscal year 2025 · $1.3MNIH RePORTER 1R44NS143521-01 · fetched Nov 12, 2026